Genetic deficiency of C3 as well as CNS-targeted expression of the complement inhibitor sCrry ameliorates experimental autoimmune uveoretinitis
- 31 March 2006
- journal article
- Published by Elsevier BV in Experimental Eye Research
- Vol. 82 (3), 389-394
- https://doi.org/10.1016/j.exer.2005.07.011
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Expression Specificity of GFAP TransgenesNeurochemical Research, 2004
- Incidence and prevalence of uveitis in Northern California The Northern California Epidemiology of Uveitis StudyOphthalmology, 2004
- Uveitis: A potentially blinding diseaseOphthalmologica, 2003
- Blockage of complement regulators in the conjunctiva and within the eye leads to massive inflammation and iritisImmunology, 2001
- Live Astrocytes Visualized by Green Fluorescent Protein in Transgenic MiceDevelopmental Biology, 1997
- Molecular characterization of rat Crry: widespread distribution of two alternative forms of Crry mRNAImmunogenetics, 1995
- Pathology of experimental autoimmune uveoretinitis in miceJournal of Autoimmunity, 1990
- Expression of C5a-like biological activities by the fifth component of human complement (C5) upon limited digestion with noncomplement enzymes without release of polypeptide fragments.The Journal of Experimental Medicine, 1983
- Chemotactic activity generated from the fifth component of complement by plasma kallikrein of the rabbit.The Journal of Experimental Medicine, 1981
- Effects of Complement Depletion on Experimental Allergic UveitisOphthalmic Research, 1979